SingHealth Institutions will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

Clin Asst Prof Michaela Seng Su-Fern

MBBS, MRCPCH, FRACP, PhD

Senior Consultant

KK Women's and Children's Hospital KK Women's and Children's Hospital

Specialty: Paediatric Medicine

Sub-Specialty: Paediatric Haematology & Oncology

Clinical Appointments

Senior Consultant

Haematology Oncology Service

Medical Director (Clinical), Blood and Marrow Transplant and Cellular Therapy

Academic Appointments

About Doctor

Dr Michaela Seng is a Senior Consultant in the Department of Paediatric Haematology and Oncology, subspecialising in Blood and Marrow Transplants and Cellular Therapies (BMTCT), with clinical expertise in high-risk childhood blood cancers, cellular therapies and haematopoietic stem cell transplants for relapsed/refractory malignant and life-limiting non-malignant diseases. Dr Seng completed a PhD in the field of translational cellular therapies under the NMRC Research Training Fellowship. She is a committed clinician scientist supported by NMRC Talent Development awards and is nationally funded for her research. Her research interest is in translational cell therapies for relapsed/refractory childhood cancers, motivated by the treatment failures in her practice.

Contributions: Dr Seng led the KKH BMTCT programme to FACT accreditation for transplant and immune effector cell therapies in 2026. She established the early frameworks of the Paediatric Oncology Survivorship Programme in Singapore and the Paediatric Transplant and Cell Therapy Registry during her junior faculty years. She is the Principal Investigator of a translational research laboratory in the Children’s Blood and Cancer Centre and is actively involved in investigator-initiated clinical trials for novel cellular therapies. 

Current Appointments: Dr. Michaela Seng holds leadership and committee appointments within the hospital, SingHealth cluster and MOH, as listed below. She holds faculty and mentor roles at the Duke-NUS Medical school and Lee Kong Chian Medical School. She volunteers as a medical sub-committee board member of the Bone Marrow Donor Programme.

Languages Spoken

  • English
  • Chinese

Education and Training

  • PhD, Duke-NUS Medical School
  • FRACP, Australia (Medical Oncology)
  • Specialist Accreditation Board (Paediatric Medicine; Paediatric Haematology/Oncology), Singapore
  • MRCPH, United Kingdom
  • MBBS, National University of Singapore

Professional Appointments and Committee Memberships

  • Research Lead, SingHealth-Duke NUS Cell Therapy Centre EXCO
  • Research Director, Singhealth-Duke NUS Transplant Centre EXCO
  • Medical Director, Blood and Marrow Transplant and Cellular Therapies, KKH
  • Co-Chair, Cell and Gene Therapy Committee, KKH
  • Research Lead (BMTCT), Children’s Blood and Cancer Centre Executive Committee, KKH
  • Member, Joint Coordinating Committee, Paediatric Haematology and Oncology, Singapore
  • Member, Academic Research Council, SingHealth
  • Member, Maternal and Child Health Research Institute, KKH
  • Member, MOH Clinical Services Strategy for Cell Therapy, Singapore
  • Medical Sub-committee, Bone Marrow Donor Programme, Singapore

Awards

  • IAF-PPP Human Health Potential ASPHALT Award, 2025, Theme PI
  • SYMPHONY Large Collaborative Grant Award, 2025, Theme Co-PI
  • NMRC Transition Award, 2023
  • NMRC Clinical Trials Grant- IIT Award, 2023
  • NMRC Research Training Fellowship Award, 2019
  • CCSD, Khoo Scholar Program, 2019
  • Best Poster Presentation award Pan Asia Summit 2024 (Team)
  • Best SingHealth Oral Paper Combined Scientific Meeting, 2005

Research Trials/Clinical Trials

Investigator-Initiated Clinical Trials

  • A Phase I/II Study of Dual aCD22-aCD19 CAR-T for relapsed/refractory B-cell ALL
  • CD19 Directed CAR-T Therapy for B-lineage leukaemias and lymphomas
  • Novel Adoptive Cellular Therapy with SARS-CoV2-specific T cells in Patients with Severe COVID-19

Leukaemia Consortium Studies

  • MASPORE ALL-Seq 2020: RNA-Seq and IgH/TCR-Seq to improve risk assignment in childhood, adolescent and young adult acute lymphoblastic leukaemia
  • Asia-wide multicenter, open-label, phase II non-randomised study involving children with Down Syndrome under 21 yo with newly diagnosed treatment naïve ALL
  • Investigating mercaptopurine dose intensity and pharmacogenomics in Asian children and adults with ALL

Solid Tumour Consortium Studies

  • UMBRELLA SIOP 2016 study for Renal Tumours
  • Paediatric Hepatic International Tumour Trial (PHITT)
  • An integrated multi-omics study on primary liver cancer and patients at risk of liver cancer

Registry/ Tissue Studies

  • Paediatric Haematopoeitic Cell Transplantation and Cell Therapy in Malignant and Non Malignant Diseases
  • Modeling, Analysis and Translational Therapeutics for Tumours of Childhood (MAT3CH)
  • Broadbased Longitudinal Analyses of Childhood Cancers and Tumours (BLAnCCaT)
  • Comprehensive Genomic Profiling of Paediatric Brain and Solid Tumours

Publications